Bibliography
Milnerwood, A. J., Gladding, C. M., Pouladi, M. A., Kaufman, A. M., Hines, R. M., Boyd, J. D., Ko, R. W. Y., Vasuta, O. C., Graham, R. K., Hayden, M. R., Murphy, T. H., & Raymond, L. A. (2010). Early Increase in Extrasynaptic NMDA Receptor Signaling and Expression Contributes to Phenotype Onset in Huntingtonâs Disease Mice. Neuron, 65(2), 178â190.
Authors
12
- Austen J. Milnerwood (first)
- Clare M. Gladding (additional)
- Mahmoud A. Pouladi (additional)
- Alexandra M. Kaufman (additional)
- Rochelle M. Hines (additional)
- Jamie D. Boyd (additional)
- Rebecca W.Y. Ko (additional)
- Oana C. Vasuta (additional)
- Rona K. Graham (additional)
- Michael R. Hayden (additional)
- Timothy H. Murphy (additional)
- Lynn A. Raymond (additional)
References
86
Referenced
432
10.1152/jn.01118.2005
/ J. Neurophysiol. / Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease by Andre (2006)10.1038/nn825
/ Nat. Neurosci. / Cooperation between independent hippocampal synapses is controlled by glutamate uptake by Arnth-Jensen (2002)10.1016/S0143-4160(03)00141-6
/ Cell Calcium / Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity by Arundine (2003)10.1038/361031a0
/ Nature / A synaptic model of memory: long-term potentiation in the hippocampus by Bliss (1993)10.1523/JNEUROSCI.4295-06.2007
/ J. Neurosci. / Extensive turnover of dendritic spines and vascular remodeling in cortical tissues recovering from stroke by Brown (2007)10.1523/JNEUROSCI.20-12-04423.2000
/ J. Neurosci. / Prolonged synaptic currents and glutamate spillover at the parallel fiber to stellate cell synapse by Carter (2000)10.1002/jnr.1244
/ J. Neurosci. Res. / NMDA receptor function in mouse models of Huntington disease by Cepeda (2001)10.1152/jn.2001.85.2.659
/ J. Neurophysiol. / Facilitated glutamatergic transmission in the striatum of D2 dopamine receptor-deficient mice by Cepeda (2001)10.1016/j.pneurobio.2006.11.001
/ Prog. Neurobiol. / The corticostriatal pathway in Huntington's disease by Cepeda (2007)10.1016/j.pneurobio.2007.03.004
/ Prog. Neurobiol. / Transcriptional signatures in Huntington's disease by Cha (2007)10.1523/JNEUROSCI.22-06-02165.2002
/ J. Neurosci. / Synaptically released glutamate activates extrasynaptic NMDA receptors on cells in the ganglion cell layer of rat retina by Chen (2002)10.1111/j.1471-4159.2006.03991.x
/ J. Neurochem. / The chemical biology of clinically tolerated NMDA receptor antagonists by Chen (2006)10.1523/JNEUROSCI.22-11-04428.2002
/ J. Neurosci. / Activity-dependent recruitment of extrasynaptic NMDA receptor activation at an AMPA receptor-only synapse by Clark (2002)10.1016/S0070-2153(06)75002-5
/ Curr. Top. Dev. Biol. / Selective neuronal degeneration in Huntington's disease by Cowan (2006)10.1523/JNEUROSCI.4619-08.2008
/ J. Neurosci. / Polyglutamine-modulated striatal calpain activity in YAC transgenic huntington disease mouse model: impact on NMDA receptor function and toxicity by Cowan (2008)10.1523/JNEUROSCI.1592-09.2009
/ J. Neurosci. / Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease by Cummings (2009)10.1073/pnas.0609408104
/ Proc. Natl. Acad. Sci. USA / mGluR5 stimulates gliotransmission in the nucleus accumbens by D'Ascenzo (2007)10.1523/JNEUROSCI.0435-08.2008
/ J. Neurosci. / Corticostriatal and thalamostriatal synapses have distinctive properties by Ding (2008)10.1016/j.biopsych.2006.11.034
/ Biol. Psychiatr. / Psychiatric symptoms in Huntington's disease before diagnosis: The Predict-HD study by Duff (2007)10.1016/j.pneurobio.2006.11.003
/ Prog. Neurobiol. / N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease by Fan (2007)10.1523/JNEUROSCI.4356-06.2007
/ J. Neurosci. / Altered NMDA receptor trafficking in a yeast artificial chromosome transgenic mouse model of Huntington's disease by Fan (2007)10.1523/JNEUROSCI.3455-07.2007
/ J. Neurosci. / Mitochondrial sensitivity and altered calcium handling underlie enhanced NMDA-induced apoptosis in YAC128 model of Huntington's disease by Fernandes (2007)10.1046/j.1460-9568.2003.02844.x
/ Eur. J. Neurosci. / Co-localization of brain-derived neurotrophic factor (BDNF) and wild-type huntingtin in normal and quinolinic acid-lesioned rat brain by Fusco (2003)10.1523/JNEUROSCI.22-12-04842.2002
/ J. Neurosci. / Calpain activation in Huntington's disease by Gafni (2002)10.1074/jbc.M401267200
/ J. Biol. Chem. / Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain/caspase fragments in the nucleus by Gafni (2004)10.1093/hmg/ddg046
/ Hum. Mol. Genet. / Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice by Gines (2003)10.1113/jphysiol.2007.134460
/ J. Physiol. / The main source of ambient GABA responsible for tonic inhibition in the mouse hippocampus by Glykys (2007)10.1038/ng0896-442
/ Nat. Genet. / Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract by Goldberg (1996)10.1016/j.mcn.2009.01.002
/ Mol. Cell. Neurosci. / Reverse glial glutamate uptake triggers neuronal cell death through extrasynaptic NMDA receptor activation by Gouix (2009)10.1016/j.cell.2006.04.026
/ Cell / Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin by Graham (2006)10.1016/j.nbd.2005.08.007
/ Neurobiol. Dis. / Levels of mutant huntingtin influence the phenotypic severity of Huntington disease in YAC128 mouse models by Graham (2006)10.1016/S0166-2236(02)00040-1
/ Trends Neurosci. / The Yin and Yang of NMDA receptor signalling by Hardingham (2003)10.1038/nn835
/ Nat. Neurosci. / Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways by Hardingham (2002)10.1523/JNEUROSCI.5599-08.2009
/ J. Neurosci. / In vivo evidence for NMDA receptor-mediated excitotoxicity in a murine genetic model of Huntington disease by Heng (2009)10.1523/JNEUROSCI.0032-08.2008
/ J. Neurosci. / Synaptic imbalance, stereotypies, and impaired social interactions in mice with altered neuroligin 2 expression by Hines (2008)10.1016/S0896-6273(00)80764-3
/ Neuron / A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration by Hodgson (1999)10.1007/s00441-006-0273-6
/ Cell Tissue Res. / NMDA receptor function: subunit composition versus spatial distribution by Köhr (2006)10.1038/nrn2153
/ Nat. Rev. Neurosci. / NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders by Lau (2007)10.1113/jphysiol.2006.123570
/ J. Physiol. / Tonic activation of NMDA receptors by ambient glutamate of non-synaptic origin in the rat hippocampus by Le Meur (2007)10.1096/fj.08-107268
/ Faseb J. / Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors by Leveille (2008)10.1152/jn.00308.2004
/ J. Neurophysiol. / Enhanced striatal NR2B-containing N-methyl-D-aspartate receptor-mediated synaptic currents in a mouse model of Huntington disease by Li (2004)10.1113/jphysiol.2004.063792
/ J. Physiol. / Extrasynaptic NR2B and NR2D subunits of NMDA receptors shape ‘superslow’ afterburst EPSC in rat hippocampus by Lozovaya (2004)10.1523/JNEUROSCI.1697-04.2004
/ J. Neurosci. / Differential roles of NR2A and NR2B-containing NMDA receptors in cortical long-term potentiation and long-term depression by Massey (2004)10.1016/j.neuroscience.2008.02.004
/ Neuroscience / Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse by Miller (2008){'key': '10.1016/j.neuron.2010.01.008_bib44', 'series-title': 'Molecular Mechanisms of Synaotogenesis', 'first-page': '457', 'article-title': "Synaptic Abnormalities Associated with Huntington's disease", 'author': 'Milnerwood', 'year': '2006'}
/ Molecular Mechanisms of Synaotogenesis / Synaptic Abnormalities Associated with Huntington's disease by Milnerwood (2006)10.1113/jphysiol.2007.142448
/ J. Physiol. / Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load by Milnerwood (2007)10.1093/hmg/ddl092
/ Hum. Mol. Genet. / Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease by Milnerwood (2006)10.1523/JNEUROSCI.20-13-05115.2000
/ J. Neurosci. / Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation by Murphy (2000)10.1038/nm.2056
/ Nat. Med. / Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin by Okamoto (2009)10.1124/jpet.108.143115
/ J. Pharmacol. Exp. Ther. / Neuronal pentraxins modulate cocaine-induced neuroadaptations by Pacchioni (2009)10.1038/nn884
/ Nat. Neurosci. / Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines by Panov (2002)10.1007/s11010-005-3454-9
/ Mol. Cell. Biochem. / Ca2+-induced permeability transition in human lymphoblastoid cell mitochondria from normal and Huntington's disease individuals by Panov (2005)10.1177/1073858407305833
/ Neuroscientist / The dichotomy of NMDA receptor signaling by Papadia (2007)10.1038/nn2071
/ Nat. Neurosci. / Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses by Papadia (2008)10.1016/j.neuropharm.2007.07.013
/ Neuropharmacology / Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system—too little activation is bad, too much is even worse by Parsons (2007)10.1093/brain/awp006
/ Brain / Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin by Pouladi (2009)10.1016/j.neuron.2005.08.016
/ Neuron / The synaptic localization of NR2B-containing NMDA receptors is controlled by interactions with PDZ proteins and AP-2 by Prybylowski (2005)10.1007/s004150170085
/ J. Neurol. / Wild-type huntingtin up-regulates BDNF transcription in Huntington's disease by Reilly (2001)10.1523/JNEUROSCI.0364-04.2004
/ J. Neurosci. / NR2B-containing receptors mediate cross talk among hippocampal synapses by Scimemi (2004)10.1093/hmg/ddi319
/ Hum. Mol. Genet. / HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism by Seong (2005)10.1016/0028-3908(93)90150-2
/ Neuropharmacology / An antagonist of glutamate metabotropic receptors, (RS)-alpha-methyl-4-carboxyphenylglycine, prevents the LTP-related increase in postsynaptic AMPA sensitivity in hippocampal slices by Sergueeva (1993)10.1016/j.nbd.2005.08.001
/ Neurobiol. Dis. / Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington disease by Shehadeh (2006)10.1093/hmg/ddg169
/ Hum. Mol. Genet. / Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease by Slow (2003)10.1111/j.1460-9568.2008.06505.x
/ Eur. J. Neurosci. / Differences in excitatory transmission between thalamic and cortical afferents to single spiny efferent neurons of rat dorsal striatum by Smeal (2008)10.1016/j.neuropsychologia.2006.12.015
/ Neuropsychologia / Verbal episodic memory declines prior to diagnosis in Huntington's disease by Solomon (2007)10.1073/pnas.0903546106
/ Proc. Natl. Acad. Sci. USA / Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity by Stanika (2009)10.1111/j.1469-7793.1998.013bu.x
/ J. Physiol. / Increased contribution of NR2A subunit to synaptic NMDA receptors in developing rat cortical neurons by Stocca (1998)10.1074/jbc.M310226200
/ J. Biol. Chem. / Decreased cAMP response element-mediated transcription: an early event in exon 1 and full-length cell models of Huntington's disease that contributes to polyglutamine pathogenesis by Sugars (2004)10.1073/pnas.0409402102
/ Proc. Natl. Acad. Sci. USA / Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease by Tang (2005)10.1523/JNEUROSCI.20-15-05581.2000
/ J. Neurosci. / Modulation of long-term depression by dopamine in the mesolimbic system by Thomas (2000)10.1038/nrn2274
/ Nat. Rev. Neurosci. / Glutamate transporters: confining runaway excitation by shaping synaptic transmission by Tzingounis (2007)10.1523/JNEUROSCI.0590-05.2005
/ J. Neurosci. / Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease by Van Raamsdonk (2005)10.1097/00005072-199805000-00001
/ J. Neuropathol. Exp. Neurol. / Huntington disease by Vonsattel (1998){'key': '10.1016/j.neuron.2010.01.008_bib73', 'first-page': '1', 'article-title': 'Huntington disease: new insights on the role of huntingtin cleavage', 'author': 'Wellington', 'year': '2000', 'journal-title': 'J. Neural Transm. Suppl.'}
/ J. Neural Transm. Suppl. / Huntington disease: new insights on the role of huntingtin cleavage by Wellington (2000)10.1523/JNEUROSCI.22-18-07862.2002
/ J. Neurosci. / Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease by Wellington (2002)10.1007/BF01181319
/ J. Neurocytol. / Thirty years of synaptosome research by Whittaker (1993)10.2174/1389450013348489
/ Curr. Drug Targets / Ifenprodil, a novel NMDA receptor antagonist: site and mechanism of action by Williams (2001)10.1523/JNEUROSCI.16-07-02397.1996
/ J. Neurosci. / The origins of two-state spontaneous membrane potential fluctuations of neostriatal spiny neurons by Wilson (1996)10.1523/JNEUROSCI.2220-05.2005
/ J. Neurosci. / NMDA/AMPA ratio impacts state transitions and entrainment to oscillations in a computational model of the nucleus accumbens medium spiny projection neuron by Wolf (2005)10.1074/jbc.M700624200
/ J. Biol. Chem. / Fyn-mediated phosphorylation of NR2B Tyr-1336 controls calpain-mediated NR2B cleavage in neurons and heterologous systems by Wu (2007)10.1093/hmg/10.17.1829
/ Hum. Mol. Genet. / Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease by Wyttenbach (2001)10.1016/S0896-6273(02)00615-3
/ Neuron / Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease by Zeron (2002)10.1016/j.mcn.2003.11.014
/ Mol. Cell. Neurosci. / Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease by Zeron (2004)10.1016/j.nbd.2008.03.010
/ Neurobiol. Dis. / Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease by Zhang (2008)10.1126/science.1059581
/ Science / Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease by Zuccato (2001)10.1016/j.phrs.2005.01.001
/ Pharmacol. Res. / Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery by Zuccato (2005)
Dates
Type | When |
---|---|
Created | 15 years, 7 months ago (Jan. 28, 2010, 6:11 a.m.) |
Deposited | 1 year, 4 months ago (April 22, 2024, 3:20 p.m.) |
Indexed | 9 hours, 13 minutes ago (Aug. 31, 2025, 7:22 p.m.) |
Issued | 15 years, 8 months ago (Jan. 1, 2010) |
Published | 15 years, 8 months ago (Jan. 1, 2010) |
Published Print | 15 years, 8 months ago (Jan. 1, 2010) |
Funders
2
Michael Smith Foundation for Health Research
10.13039/501100000245
Michael Smith Health Research BCRegion: Americas
pri (Trusts, charities, foundations (both public and private))
Labels
2
- Michael Smith Foundation for Health Research
- MSFHR
Canadian Institutes of Health Research
10.13039/501100000024
Region: Americas
gov (National government)
Labels
6
- Instituts de Recherche en Santé du Canada
- Canadian Institutes of Health Research (CIHR)
- CIHR_IRSC
- Canadian Institutes of Health Research | Ottawa ON
- CIHR
- IRSC
Awards
1
- MOP-12699
@article{Milnerwood_2010, title={Early Increase in Extrasynaptic NMDA Receptor Signaling and Expression Contributes to Phenotype Onset in Huntington’s Disease Mice}, volume={65}, ISSN={0896-6273}, url={http://dx.doi.org/10.1016/j.neuron.2010.01.008}, DOI={10.1016/j.neuron.2010.01.008}, number={2}, journal={Neuron}, publisher={Elsevier BV}, author={Milnerwood, Austen J. and Gladding, Clare M. and Pouladi, Mahmoud A. and Kaufman, Alexandra M. and Hines, Rochelle M. and Boyd, Jamie D. and Ko, Rebecca W.Y. and Vasuta, Oana C. and Graham, Rona K. and Hayden, Michael R. and Murphy, Timothy H. and Raymond, Lynn A.}, year={2010}, month=jan, pages={178–190} }